Human transcriptional signature of protection after Plasmodium falciparum immunization and infectious challenge via mosquito bites

References

• Laurens MB. RTS,S/AS01 vaccine (Mosquirix): an overview. Hum Vaccin Immunother. 2020;16:480–12. doi:10.1080/21645515.2019.1669415.
   PubMed Web of Science ®Google Scholar
• Rts SCTP. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11(7):e1001685. doi:10.1371/journal.pmed.1001685.
   PubMed Web of Science ®Google Scholar
• Datoo MS, Natama HM, Some A, Bellamy D, Traore O, Rouamba T, Tahita MC, Ido NFA, Yameogo P, Valia D, et al. Efficacy and immunogenicity of R21/matrix-M vaccine against clinical malaria after 2 years’ follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. Lancet Infect Dis. 2022;22(12):1728–36. doi:10.1016/S1473-3099(22)00442-X.
   PubMed Web of Science ®Google Scholar
• Datoo MS, Natama MH, Some A, Traore O, Rouamba T, Bellamy D, Yameogo P, Valia D, Tegneri M, Ouedraogo F, et al. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet. 2021;397(10287):1809–18. doi:10.1016/S0140-6736(21)00943-0.
   PubMed Web of Science ®Google Scholar
• Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A, et al. Attenuated PfSPZ vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci USA. 2017;114(10):2711–6. doi:10.1073/pnas.1615324114.
   PubMed Web of Science ®Google Scholar
• Lyke KE, Singer A, Berry AA, Reyes S, Chakravarty S, James ER, Billingsley PF, Gunasekera A, Manoj A, Murshedkar T, et al. Multidose priming and delayed boosting improve Plasmodium falciparum sporozoite vaccine efficacy against Heterologous P. falciparum controlled human malaria infection. Clin Infect Dis. 2021;73(7):e2424–e35. doi:10.1093/cid/ciaa1294.
   PubMed Web of Science ®Google Scholar
• Mordmuller B, Sulyok Z, Sulyok M, Molnar Z, Lalremruata A, Calle CL, Bayon PG, Esen M, Gmeiner M, Held J, et al. A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection. NPJ Vaccines. 2022;7(1):100. doi:10.1038/s41541-022-00510-z.
   PubMed Web of Science ®Google Scholar
• Sulyok Z, Fendel R, Eder B, Lorenz FR, Kc N, Karnahl M, Lalremruata A, Nguyen TT, Held J, Adjadi FAC, et al. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. Nat Commun. 2021;12(1):2518. doi:10.1038/s41467-021-22740-w.
   PubMed Web of Science ®Google Scholar
• Clyde DF, McCarthy VC, Miller RM, Hornick RB. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci. 1973;266:398–403. doi:10.1097/00000441-197312000-00001.
   PubMed Web of Science ®Google Scholar
• Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature. 1967;216(5111):160–2. doi:10.1038/216160a0.
   PubMed Web of Science ®Google Scholar
• Rieckmann KH, Beaudoin RL, Cassells JS, Sell KW. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ. 1979;57:261–5.
   PubMedGoogle Scholar
• Goh YS, McGuire D, Renia L. Vaccination with sporozoites: models and correlates of protection. Front Immunol. 2019;10:1227. doi:10.3389/fimmu.2019.01227.
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002;185(8):1155–64. doi:10.1086/339409.
   PubMed Web of Science ®Google Scholar
• Bergmann-Leitner ES, Mease RM, De La Vega P, Savranskaya T, Polhemus M, Ockenhouse C, Angov E, Moorthy V. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei. PLoS One. 2010;5(8):e12294. doi:10.1371/journal.pone.0012294.
   PubMed Web of Science ®Google Scholar
• Doolan DL, Southwood S, Freilich DA, Sidney J, Graber NL, Shatney L, Bebris L, Florens L, Dobano C, Witney AA, et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci USA. 2003;100(17):9952–7. doi:10.1073/pnas.1633254100.
   PubMed Web of Science ®Google Scholar
• Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, Baldi P, Felgner PL, Doolan DL. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mole Cell Prot. 2011;10(9):M111 007948. doi:10.1074/mcp.M111.007948.
   PubMed Web of Science ®Google Scholar
• Bergmann ES, Ballou RW, Krzych U. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites. Cell Immunol. 1997;180(2):143–52. doi:10.1006/cimm.1997.1186.
   PubMed Web of Science ®Google Scholar
• Doll KL, Harty JT. Correlates of protective immunity following whole sporozoite vaccination against malaria. Immunol Res. 2014;59(1–3):166–76. doi:10.1007/s12026-014-8525-0.
   PubMed Web of Science ®Google Scholar
• Doll KL, Pewe LL, Kurup SP, Harty JT. Discriminating protective from nonprotective Plasmodium-specific CD8+ T cell responses. J Immunol. 2016;196(10):4253–62. doi:10.4049/jimmunol.1600155.
   PubMed Web of Science ®Google Scholar
• Abuga KM, Jones-Warner W, Hafalla JCR. Immune responses to malaria pre-erythrocytic stages: implications for vaccine development. Parasite Immunol. 2021;43(2):e12795. doi:10.1111/pim.12795.
   PubMed Web of Science ®Google Scholar
• Mura M, Atre T, Savransky T, Bergmann-Leitner ES. Differential homing receptor profiles of lymphocytes induced by attenuated versus live Plasmodium falciparum sporozoites. Vaccines (Basel). 2022;10(10):10. doi:10.3390/vaccines10101768.
   Web of Science ®Google Scholar
• Mura M, Lu P, Atre T, Bolton JS, Duncan EH, Chaudhury S, Bergmann-Leitner ES. Immunoprofiling identifies functional B and T cell subsets induced by an attenuated whole parasite malaria vaccine as correlates of sterile immunity. Vaccines (Basel). 2022;10(1). doi:10.3390/vaccines10010124.
   Web of Science ®Google Scholar
• Hickey B, Teneza-Mora N, Lumsden J, Reyes S, Sedegah M, Garver L, Hollingdale MR, Banania JG, Ganeshan H, Dowler M, et al. IMRAS—A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents. PLoS One. 2020;15:e0233840. doi:10.1371/journal.pone.0233840.
   PubMed Web of Science ®Google Scholar
• Du Y, Hertoghs N, Duffy FJ, Carnes J, McDermott SM, Neal ML, Schwedhelm KV, McElrath MJ, De Rosa SC, Aitchison JD, et al. Systems analysis of immune responses to attenuated P. falciparum malaria sporozoite vaccination reveals excessive inflammatory signatures correlating with impaired immunity. PLoS Pathog. 2022;18(2):e1010282. doi:10.1371/journal.ppat.1010282.
   PubMed Web of Science ®Google Scholar
• Duffy FJ, Du Y, Carnes J, Epstein JE, Hoffman SL, Abdulla S, Jongo S, Mpina M, Daubenberger C, Aitchison JD, et al. Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naive and malaria pre-exposed adult volunteers. Malar J. 2021;20:308. doi:10.1186/s12936-021-03839-3.
   PubMed Web of Science ®Google Scholar
• Duffy FJ, Hertoghs N, Du Y, Neal ML, Oyong D, McDermott S, Minkah N, Carnes J, Schwedhelm KV, McElrath MJ, et al. Longitudinal immune profiling after radiation-attenuated sporozoite vaccination reveals coordinated immune processes correlated with malaria protection. Front Immunol. 2022;13:1042741. doi:10.3389/fimmu.2022.1042741.
   PubMed Web of Science ®Google Scholar
• Simms PE, Ellis TM. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin Diagn Lab Immunol. 1996;3(3):301–4. doi:10.1128/cdli.3.3.301-304.1996.
   PubMedGoogle Scholar
• Tough DF, Sun S, Sprent J. T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med. 1997;185(12):2089–94. doi:10.1084/jem.185.12.2089.
   PubMed Web of Science ®Google Scholar
• Fu Y, Ding Y, Wang Q, Zhu F, Tan Y, Lu X, Guo B, Zhang Q, Cao Y, Liu T, et al. Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. Sci Adv. 2020;6:eaay9269. doi:10.1126/sciadv.aay9269.
   PubMed Web of Science ®Google Scholar
• Keitany GJ, Kim KS, Krishnamurty AT, Hondowicz BD, Hahn WO, Dambrauskas N, Sather DN, Vaughan AM, Kappe SHI, Pepper M. Blood stage malaria disrupts humoral immunity to the pre-erythrocytic stage circumsporozoite protein. Cell Rep. 2016;17(12):3193–205. doi:10.1016/j.celrep.2016.11.060.
   PubMed Web of Science ®Google Scholar
• Woodberry T, Minigo G, Piera KA, Amante FH, Pinzon-Charry A, Good MF, Lopez JA, Engwerda CR, McCarthy JS, Anstey NM. Low-level Plasmodium falciparum blood-stage infection causes dendritic cell apoptosis and dysfunction in healthy volunteers. J Infect Dis. 2012;206(3):333–40. doi:10.1093/infdis/jis366.
   PubMed Web of Science ®Google Scholar
• Burel JG, Babor M, Pomaznoy M, Lindestam Arlehamn CS, Khan N, Sette A, Peters B. Host transcriptomics as a tool to identify diagnostic and mechanistic immune signatures of tuberculosis. Front Immunol. 2019;10:221. doi:10.3389/fimmu.2019.00221.
   PubMed Web of Science ®Google Scholar
• Mura M, Chaudhury S, Farooq F, Duncan EH, Beck K, Bergmann-Leitner ES. Optimized flow cytometric protocol for the detection of functional subsets of low frequency antigen-specific CD4(+) and CD8(+) T cells. MethodsX. 2020;7:101005. doi:10.1016/j.mex.2020.101005.
   PubMed Web of Science ®Google Scholar
• Jones EF, Haldar A, Oza VH, Lasseigne BN. Quantifying transcriptome diversity: a review. Brief Funct Genomics. 2023. doi:10.1093/bfgp/elad019.
   PubMed Web of Science ®Google Scholar
• Bashkeel N, Perkins TJ, Kaern M, Lee JM. Human gene expression variability and its dependence on methylation and aging. BMC Genom. 2019;20(1):941. doi:10.1186/s12864-019-6308-7.
   PubMed Web of Science ®Google Scholar
• Sa ACC, Sadee W, Johnson JA. Whole transcriptome profiling: an RNA-Seq primer and implications for pharmacogenomics research. Clin Transl Sci. 2018;11:153–61. doi:10.1111/cts.12511.
   PubMed Web of Science ®Google Scholar
• Farooq F, Beck K, Paolino KM, Phillips R, Waters NC, Regules JA, Bergmann-Leitner ES. Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine. Sci Rep. 2016;6(1):27944. doi:10.1038/srep27944.
   PubMedGoogle Scholar
• Magnetic enrichment of antigen-specific CD4+ T cells enables the in-depth characterization of vaccine-induced circulating follicular T helper cells. https://static.miltenyibiotec.com/asset/150655405641/document_khoqgsfsqd1kl6gv9e27rp5o11?content-disposition=inline.
   Google Scholar
• Oyong DA, Duffy FJ, Neal ML, Du Y, Carnes J, Schwedhelm KV, Hertoghs N, Jun SH, Miller H, Aitchison JD, et al. Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge. PLoS Pathog. 2023;19(5):e1011051. doi:10.1371/journal.ppat.1011051.
   PubMed Web of Science ®Google Scholar
• Gupta A, Galinski MR, Voit EO. Dynamic control balancing cell proliferation and inflammation is crucial for an effective immune response to malaria. Front Mol Biosci. 2021;8:800721. doi:10.3389/fmolb.2021.800721.
   PubMed Web of Science ®Google Scholar
• Sharma S, DeOliveira RB, Kalantari P, Parroche P, Goutagny N, Jiang Z, Chan J, Bartholomeu DC, Lauw F, Hall JP, et al. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity. 2011;35(2):194–207. doi:10.1016/j.immuni.2011.05.016.
   PubMed Web of Science ®Google Scholar
• Haque A, Best SE, Ammerdorffer A, Desbarrieres L, de Oca MM, Amante FH, de Labastida Rivera F, Hertzog P, Boyle GM, Hill GR, et al. Type I interferons suppress CD4(+) T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur J Immunol. 2011;41:2688–98. doi:10.1002/eji.201141539.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Georgiadou A, Walther M, Nwakanma D, Stewart LB, Levin M, Otto TD, Conway DJ, Coin LJ, Cunnington AJ. Integrated pathogen load and dual transcriptome analysis of systemic host-pathogen interactions in severe malaria. Sci Transl Med. 2018;10(447). doi:10.1126/scitranslmed.aar3619.
   Web of Science ®Google Scholar
• Mooney JP, Wassmer SC, Hafalla JC. Type I interferon in malaria: a balancing act. Trends Parasitol. 2017;33(4):257–60. doi:10.1016/j.pt.2016.12.010.
   PubMed Web of Science ®Google Scholar
• Yu X, Cai B, Wang M, Tan P, Ding X, Wu J, Li J, Li Q, Liu P, Xing C, et al. Cross-regulation of two type I interferon signaling pathways in plasmacytoid dendritic cells controls anti-malaria immunity and host mortality. Immunity. 2016;45(5):1093–107. doi:10.1016/j.immuni.2016.10.001.
   PubMed Web of Science ®Google Scholar
• Marques-da-Silva C, Peissig K, Walker MP, Shiau J, Bowers C, Kyle DE, Vijay R, Lindner SE, Kurup SP. Direct type I interferon signaling in hepatocytes controls malaria. Cell Rep. 2022;40(3):111098. doi:10.1016/j.celrep.2022.111098.
   PubMed Web of Science ®Google Scholar
• Miller JL, Sack BK, Baldwin M, Vaughan AM, Kappe SHI. Interferon-mediated innate immune responses against malaria parasite liver stages. Cell Rep. 2014;7(2):436–47. doi:10.1016/j.celrep.2014.03.018.
   PubMed Web of Science ®Google Scholar
• Kazmin D, Nakaya HI, Lee EK, Johnson MJ, van der Most R, van den Berg RA, Ballou WR, Jongert E, Wille-Reece U, Ockenhouse C, et al. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans. Proc Natl Acad Sci USA. 2017;114(9):2425–30. doi:10.1073/pnas.1621489114.
   PubMed Web of Science ®Google Scholar
• Vahey MT, Wang Z, Kester KE, Cummings J, Heppner DG Jr., Nau ME, Ofori-Anyinam O, Cohen J, Coche T, Ballou WR, et al. Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine. J Infect Dis. 2010;201(4):580–9. doi:10.1086/650310.
   PubMed Web of Science ®Google Scholar
• Arora G, Hart GT, Manzella-Lapeira J, Doritchamou JY, Narum DL, Thomas LM, Brzostowski J, Rajagopalan S, Doumbo OK, Traore B, et al. NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity. Elife. 2018;7. doi:10.7554/eLife.36806.
   Web of Science ®Google Scholar
• Larsen MD, Lopez-Perez M, Dickson EK, Ampomah P, Tuikue Ndam N, Nouta J, Koeleman CAM, Ederveen ALH, Mordmuller B, Salanti A, et al. Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination. Nat Commun. 2021;12(1):5838. doi:10.1038/s41467-021-26118-w.
   PubMed Web of Science ®Google Scholar
• Odera DO, Tuju J, Mwai K, Nkumama IN, Furle K, Chege T, Kimathi R, Diehl S, Musasia FK, Rosenkranz M, et al. Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria. Sci Transl Med. 2023;15(682):eabn5993. doi:10.1126/scitranslmed.abn5993.
   PubMed Web of Science ®Google Scholar
• Ty M, Sun S, Callaway PC, Rek J, Press KD, van der Ploeg K, Nideffer J, Hu Z, Klemm S, Greenleaf W, et al. Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria. Sci Transl Med. 2023;15(680):eadd9012. doi:10.1126/scitranslmed.add9012.
   PubMed Web of Science ®Google Scholar
• Bartholomeus E, De Neuter N, Meysman P, Suls A, Keersmaekers N, Elias G, Jansens H, Hens N, Smits E, Van Tendeloo V, et al. Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders. Vaccine. 2018;36(42):6282–9. doi:10.1016/j.vaccine.2018.09.001.
   PubMed Web of Science ®Google Scholar
• Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, Germain RN, Wang E, Olnes MJ, Narayanan M, Golding H, et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell. 2014;157(2):499–513. doi:10.1016/j.cell.2014.03.031.
   PubMed Web of Science ®Google Scholar
• Tsang JS, Dobano C, VanDamme P, Moncunill G, Marchant A, Othman RB, Sadarangani M, Koff WC, Kollmann TR. Improving vaccine-induced immunity: can baseline predict outcome? Trends Immunol. 2020;41(6):457–65. doi:10.1016/j.it.2020.04.001.
   PubMed Web of Science ®Google Scholar
• Nono JK, Kamdem SD, Musaigwa F, Nnaji CA, Brombacher F. Influence of schistosomiasis on host vaccine responses. Trends Parasitol. 2022;38(1):67–79. doi:10.1016/j.pt.2021.07.009.
   PubMed Web of Science ®Google Scholar
• Galaxy C. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 2022;50:W345–W51. doi:10.1093/nar/gkac247.
   PubMed Web of Science ®Google Scholar
• FastQC: a quality control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
   Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. doi:10.1093/bioinformatics/bts635.
   PubMed Web of Science ®Google Scholar
• Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–30. doi:10.1093/bioinformatics/btt656.
   PubMed Web of Science ®Google Scholar
• Ewels P, Magnusson M, Lundin S, Kaller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047–8. doi:10.1093/bioinformatics/btw354.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. EdgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40. doi:10.1093/bioinformatics/btp616.
   PubMed Web of Science ®Google Scholar
• Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, Baldwin N, Stichweh D, Blankenship D, Li L, Munagala I, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity. 2008;29(1):150–64. doi:10.1016/j.immuni.2008.05.012.
   PubMed Web of Science ®Google Scholar
• Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2014;15(2):195–204. doi:10.1038/ni.2789.
   PubMed Web of Science ®Google Scholar